Summary
Updated Aug 30, 2026
Eugene Durenard files SEC Form 4 reports at Co-Diagnostics, Inc. (CODX). 4 SEC Form 4 filings on record going back to 2024, most recently on 27 May 2026.
Recent Transactions
3Every recent SEC Form 4 transaction Eugene Durenard has reported, most recent first.
Other Insiders Active in the Same Sector
No other insider has filed at Eugene Durenard's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- RA CAPITAL MANAGEMENT, L.P. - $117.62M of ARTV open-market activity in the last 12 months
- SVF Pauling (Cayman) Ltd - $116.40M of RLAY open-market activity in the last 12 months
- Bain Capital Life Sciences Investors, LLC - $115.00M of HTFL open-market activity in the last 12 months
- Herriot Tabuteau - $110.58M of AXSM open-market activity in the last 12 months
- Mayukh Sukhatme - $109.13M of ROIV open-market activity in the last 12 months
- Michael Simanovsky - $105.88M of SNDA open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Eugene Durenard?
Eugene Durenard is a corporate insider of Co-Diagnostics, Inc. (CODX). InsiderAlpha holds 4 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Eugene Durenard last file a Form 4?
The most recent primary Form 4 on record is dated 27 May 2026, one of 4 filings going back to 2024.
Where can I see all of Eugene Durenard's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Eugene Durenard and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
